Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Number of holders
-
229
-
Total 13F shares, excl. options
-
19,725,780
-
Shares change
-
-311,184
-
Total reported value, excl. options
-
$1,287,090,849
-
Value change
-
-$20,870,018
-
Put/Call ratio
-
64%
-
Number of buys
-
115
-
Number of sells
-
-99
-
Price
-
$65.25
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q2 2025
257 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q2 2025.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 229 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19,725,780 shares
of 22,278,088 outstanding shares and own 89% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2,580,537 shares), VANGUARD GROUP INC (1,277,354 shares), MILLENNIUM MANAGEMENT LLC (1,003,876 shares), Global Alpha Capital Management Ltd. (862,090 shares), STATE STREET CORP (716,117 shares), Deep Track Capital, LP (700,000 shares), CITADEL ADVISORS LLC (569,630 shares), DIMENSIONAL FUND ADVISORS LP (553,893 shares), Ranger Investment Management, L.P. (534,233 shares), and WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (490,536 shares).
This table shows the top 229 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.